Nordea Investment Management Ab G1 Therapeutics, Inc. Transaction History

Nordea Investment Management Ab

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$4.04 - $8.51 $1.61 Million - $3.38 Million	-397,746 Closed	0 $0
Q1 2022 Apr 11, 2022	BUY	$7.6 - $11.02 $42,833 - $62,108	5,636 Added 1.44%	397,746 $3.13 Million
Q4 2021 Jan 20, 2022	SELL	$10.16 - $16.17 $45,841 - $72,959	-4,512 Reduced 1.14%	392,110 $4.12 Million
Q3 2021 Nov 01, 2021	SELL	$13.16 - $22.47 $5.22 Million - $8.91 Million	-396,622 Reduced 50.0%	396,622 $5.45 Million
Q3 2021 Nov 01, 2021	BUY	$13.16 - $22.47 $7.95 Million - $13.6 Million	603,929 Added 319.01%	793,244 $10.6 Million
Q2 2021 Jul 16, 2021	BUY	$19.57 - $26.32 $3.7 Million - $4.98 Million	189,315 New	189,315 $4.15 Million

3.55M

11.7K

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

Get notified when there are updates to the investment portfolio of Nordea Investment Management Ab, based on Form 13F filings with the SEC.

Stay updated on Nordea Investment Management Ab with notifications on news.